ID

15114

Description

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet; ODM derived from: https://clinicaltrials.gov/show/NCT00118950

Link

https://clinicaltrials.gov/show/NCT00118950

Keywords

Versions (1)
  1. 5/16/16 5/16/16 -
Uploaded on

May 16, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 2 NCT00118950

English

Eligibility Diabetes Mellitus, Type 2 NCT00118950

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type-2 diabetes, defined as:
Description

diabetes type 2

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
age at onset of diabetes ≥ 40 years
Description

age at onset

Data type

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0332162
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
Description

serum c-peptide

Data type

boolean

Alias
UMLS CUI [1]
C0006558
no history of ketonuria or ketoacidosis .
Description

ketonuria or ketoacidosis

Data type

boolean

Alias
UMLS CUI [1,1]
C0162275
UMLS CUI [1,2]
C0011880
bmi ≤ 27 kg/m2.
Description

bmi

Data type

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
Description

plasma-glucose

Data type

boolean

Alias
UMLS CUI [1]
C0202042
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
Description

weight-loss

Data type

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0439792
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type-1 diabetes
Description

diabetes type 1

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
insulin-treated type-2 diabetes
Description

diabetes type

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
UMLS CUI [1,3]
C0745343
secondary diabetes, heart-failure
Description

diabetes

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0277555
UMLS CUI [1,3]
C0018801
serum-creatinine above the upper limit
Description

creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
serum-asat elevated more than 3 fold above the upper limit
Description

asat

Data type

boolean

Alias
UMLS CUI [1]
C0201899
factor ii-vii-x decreased below 0.7
Description

blood coagulating factor

Data type

boolean

Alias
UMLS CUI [1,1]
C0005789
UMLS CUI [1,2]
C0547047
ongoing coexisting illnesses with a life-shortening prognosis
Description

life shortening comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0023671
mental retardation or reduced intellectual behaviour
Description

mental retardation

Data type

boolean

Alias
UMLS CUI [1]
C0025362
pregnancy
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
Description

drug-abuse

Data type

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0019018
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00118950

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
diabetes type 2
Item
type-2 diabetes, defined as:
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
age at onset
Item
age at onset of diabetes ≥ 40 years
boolean
C0001779 (UMLS CUI [1,1])
C0332162 (UMLS CUI [1,2])
serum c-peptide
Item
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
boolean
C0006558 (UMLS CUI [1])
ketonuria or ketoacidosis
Item
no history of ketonuria or ketoacidosis .
boolean
C0162275 (UMLS CUI [1,1])
C0011880 (UMLS CUI [1,2])
bmi
Item
bmi ≤ 27 kg/m2.
boolean
C1305855 (UMLS CUI [1])
plasma-glucose
Item
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
boolean
C0202042 (UMLS CUI [1])
hba1c
Item
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
boolean
C0019018 (UMLS CUI [1])
weight-loss
Item
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
boolean
C1262477 (UMLS CUI [1,1])
C0439792 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
diabetes type 1
Item
type-1 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
diabetes type
Item
insulin-treated type-2 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0745343 (UMLS CUI [1,3])
diabetes
Item
secondary diabetes, heart-failure
boolean
C0011849 (UMLS CUI [1,1])
C0277555 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
creatinine
Item
serum-creatinine above the upper limit
boolean
C0201976 (UMLS CUI [1])
asat
Item
serum-asat elevated more than 3 fold above the upper limit
boolean
C0201899 (UMLS CUI [1])
blood coagulating factor
Item
factor ii-vii-x decreased below 0.7
boolean
C0005789 (UMLS CUI [1,1])
C0547047 (UMLS CUI [1,2])
life shortening comorbidity
Item
ongoing coexisting illnesses with a life-shortening prognosis
boolean
C0009488 (UMLS CUI [1,1])
C0023671 (UMLS CUI [1,2])
mental retardation
Item
mental retardation or reduced intellectual behaviour
boolean
C0025362 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
drug-abuse
Item
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
boolean
C0013146 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial